Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

SIGNATURE PAGE
IN WITNESS WHEREOF, the parties hereto have executed this Agreement in duplicate originals by their duly authorized officers or representatives.
FOR OHSU:
                 
By:
  /s/ Todd Sherer       6-27-03    
 
               
 
  Todd T. Sherer, Ph.D.       Date    
 
  Director, Technology and Research Collaborations            
Mailing Address for Notices:
Technology and Research Collaborations
Oregon Health & Science University
2525 SW 1st Ave, Suite 120
Portland, Oregon 97201
FOR OREXIGEN THERAPEUTICS, INC.:
                 
By:
  /s/ Eckard Weber       7-14-03    
 
               
 
  Eckard Weber, MD       Date    
 
  CEO, Orexigen Therapeutics, Inc.            
Mailing Address for Notices:
28202 Cabot Road, Suite 200
Laguna Niguel, CA 92677